CD4 and inflammatory bowel disease: Although the detailed etiology and pathogenesis of IBD remain uncertain, recent experimental and clinical studies have suggested that the dysregulation of mucosal CD4+ T cells, which contributes to intestinal inflammation and mucosal barrier destruction, is one of the most important aspects of the pathogenesis [2, 3].